LiteraturaKarcinomi ženskog spolnog sustava: rak stidnice, rak vulve, rak vagine, rak vrata maternice, rak cerviksa, rak endometrija, rak jajovoda, rak jajnika.
Kontakt Forum RSS
Onkologija
Najznačajnija spoznaja tijekom posljednjih godina jeste ta da je karcinom izlječiva bolest, a najznačajniji čimbenik uspješnog liječenja bilo kojeg oblika raka je rana dijagnostika.

Literatura

Datum zadnje izmjene: 14. veljače 2013.

Ginekološka onkologija


Arbeitsgemeinschaft für gynäkologische Onkologie der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe, Manual der gynäkologischen Onkologie. Springer Verlag Wien New York 1993

Bender H.G. Gynäkologische Onkologie, 2. Auflage. Georg Thieme Verlag Stuttgart New York 1991

Dall P. Innovative gynäkologische Onkologie. Gynäkologie 2002; 35: 867-871

Hochuli E. Geburtshilfe, Gynäkologie und Grenzgebiete 3. Auflage. Verlag Hans Huber Vern 1996

Knörr K, Knörr-Gärtner H, Beller FK, Lauritzen C. Geburtshilfe und Gynäkologie, 3. Auflage. Springer Verlag Berlin Heidelberg New York Paris Tokyo Hong Kong 1989

Weghaupt K.
Das Vulvakarzinom und seine Behandlung, gynäkol.prax. 1985; 9: 109-115

Weiderpass E, Ye E, Tamimi R, Trichopolous D, Nyren O, Vainio H, Adami HO. Alcoholism and Risk for Cancer of the Cervix Uteri, Vagina and Vulva. Cancer Epidemiol Biomark Prev 2001; Vol 10: 899-901

Eibach HW, Zippel HH. Klinische und pathomorphologische Untersuchungen zur präkanzerösen Bedeutung und prognostischen Wertung epithelialer Vulvaveränderungen, Geb Fra 1986; 46: 495-500

Küppers V. Behandlung der Präneoplasien von Vulva und Vagina, Gynäkologe 2001; Vol 34 (7): 603-607

Schnürch H.-G. Therapie des Vulva- und Vaginalkarzinoms. Gynäkologe 2001; Vol 34 (7): 608-618

Barke A. Frommhold H. Radiotherapie des Vulvakarzinoms. Gynäkologe, 2001; Vol 34 (7): 619-626

Garbe C. Differenzialdiagnose pigmentierter Hautveränderungen und Melanombehandlung am unteren Genitaltrakt der Frau. Gynäkologe 2001; Vol 34 (7): 634-640

Küng F.
Lichen sclerosus - hormonelle Therapie heute, Gynäkologisch-geburtshilflicher Rundschau 2000; 40 (1): 29-32

Teichmann AT, Kuhn W, Gallwitz U. Primäre und sekundäre Vaginalmalignome, gynäkol. prax. 1985; 9: 7-14

Interdisziplinäres Tumorzentrum Tübingen, Zervixkarzinom. Juni 1996

Leodolter S. Zervixkarzinom Öster Ärztezeitung 1998; 4:32-37

Bradley JP: Quickreview: Cervical Cancer. The Internet J Gynecol Obstet; 2002; (1):2

Munoz N. Human Papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000; 19 (-12):1-5

Nobbenhuis MA, Meijer CJ, van den Brule AJ, Rozendaal L, Voorhorst FJ et al. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br J Cancer 2001; 84 (6):796-801

Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, Lerenzato M et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women.

Castellsague X, Bosch X, Munoz N, Meijer CJL, Shah KV et al. Male Circumcision, Penile Human Papillomavirus Infection, and Cervical Cancer in Female Partners. N Engl J Med 2002; Vol 346 (15): 1105-1112

Iftner T, Holz B. HPV und Zervixkarzinom - Fragen und Antworten. Frauenarzt 2002; (43) 4:438-441

Zenilman JM. Chlamydia and Cervical Cancer, Editorial. JAMA 2001, Vol 285 (1):94

Koskela P, Antilla T, Bjorge t, Brunsvig a et al. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 2000, Vol 85 (1): 35-9

Antilla T, Saikku P, Koskela P, Bloigu a, Dillner J et al. Serotypes of Chlamydia trachomatis and risk for Development of Cervical Squamous Cell Carcinoma. JAMA, 2001, Vol 285 (1):47-51


Silz T, Sudik R, Pöschel B. Differenziertes Vorgehensweise bei suspekten Zytologiebefunden der Cervix uteri, gyn 1996; (1): 30-32

Ikenberg H. HPV und intraepitheliale Neoplasien des unteren Genitales. Gynäkologe 2001; Vol 34 (7): 599-602

Schlecht N, Kulage S, Robitaille J, Ferreira S, Santos M, Miyamura R, Duarte-Franco E, Rohan T, Ferenczy A, Villa LL, Franco EL. Persistent Human Papilomavirus Infection as a Predictor of Cervical Intraepithelial Neoplasia. JAMA 2001; Vol 286: 3106-3114

Bettelheim D, Gerstner GJ. Rauchen und Zervixkarzinom. Öst. Ärztezeitg 1994, Vol 49 /24): 34-36

Rheintaller A. Kommentar zur ACOG Committee Opinion, Die Bedeutung der elektochirurgischen Schlingenresektionen bei der Beurteilung von abnormalen Pap-Test, Seminar des Frauenarztes, Frauenarzt, 1998; 3: 451 - 453

Beller FK. Zervixkarzinom in der Schwangerschaft, Frauenarzt, 1997; 4: 694-695

Beck L, Berg D, Leidenberger E, Pfleiderer A. Die Früherkennung des Zervixkarzinoms, Gynäkologe 1996; 29: 781-794

Link M, Menton M. Zur Bedeutung der kolposkopischen Untersuchung bei der Früherkennung des Zervixkarzinoms, Frauenarzt, 1998, 3: 380-391

Mikhail MS, Palan PR, Romney SL. Coenzyme Q(10) and alpha-tocopherol concentrations in cervical intraepithelial neoplasia and cervix cancer. Obstet Gynecol 2001; 97 (4 Suppl 1): S3

Tumorzentrum München. Endometriumkarzinom, Empfehlungen zur Diagnostik, Therapie und Nachsorge. Nachdruck 1997

Interdisziplinäres Tumorzentrum Tübingen. Endometriumkarzinom. Juni 1996

Littman AJ, Voigt LF, Beresford SAA, Weiss NS. Recreational Physical Activity and Endometrial Cancer Risk. Am J Epidemiol 2001; Vol 154 (10) 924-933

Littman AJ, Beresford SAA, White E. The association of dietary fat and plant foods with endometrial cancer. Cancer Caus Control 2001; Vol 12 (8): 691-702

The Minnesota Cancer Prevention Research Unit Case-Control Study. Fruits, Vegetables, and Adenomatous Polyps. Am J Epidemiol 2002; Vol 155 (12): 1104-1113

Nakanishi T, Ishikawa H, Suzuki Y, Inoue T, Nakamura S, Kuzuya K. Association between menopausal state and prognosis of endometrial cancer. Int J Gynecol Cancer 2001; Vol 11 (6): 483-487

Olson SH, Mignonge L, Nakraseive C, Caputo TA, Barakat RR, Harlap S. Symptoms of Ovarian Cancer. Obstet Gynecol 2001, Vol 98 (2): 212-217

Pildner von Steinburg S, Schmalfeldt B, Kiechle M. Operativ-medikamentöses Behandlungskonzept beim Ovarialkarzinom. Frauenarzt 2003 (44) 3:258-266

Rodriguez C, Patel AV, Calle EE, Jacob EJ, Thun MJ. Estrogen Replacement Therapy and Ovarian Cancer Mortality in a large Prospective Study of US Women. JAMA 2001, Vol 285 (11):1460-1465

Diestl J, Buchholz F, Stoll P. Das ovarielle Deckepithel und seine histogenetische Beziehung zum Ovarialkarzinom, Geb Fra 1986; 46: 561-56

Harlap S, Olson SH, Curtin JP, Caputo TA, Nakraseive C, Sanchez D, Xue X. Epithelial Ovarian Carcinoma and Fertility of Parents. Epidemiol 2002; Vol 13 (1): 59-65

Stegner HE. Der ungewöhnliche Ovarialtumor Grundlagen einer typengerechten Therapie, Frauenarzt 1998: 3: 432-436

Interdisziplinäres Tumorzentrum Tübingen. Ovarialkarzinom. Juni 1996

Schildkraut JM, Calingaert B, Marchbanks PA, Moorman PG, Rodriguez GC. Impact of Progestin and Estrogen Potency in Oral Contraceptives on Ovarian Cancer Risk. J Natl Cancer Inst 2002; Vol 94 (1): 32-38

Schildkraut JM, Cooper GS, Halabi S, Calingaert B, Hartge P, Whittemore AS. Age of natural menopause and the risk of epithelial ovarian cancer. Obstet Gynecol 2001; 98 (1): 85-90

Riman T, Dickman P, Nilsson S, Correia N, Nordlinder H, Magnusson CM, Persson I. Risk Factors for Epithelial Borderline Ovarian Tumors: Results of a Swedish Case-Control Study. Gyn Oncol 2001; Vol 83:575-585

Narod SA, Sun P, Ghadirian P, Lynch H, Isaacs C, Garber J et al. Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. Lancet 2001, 357 (9257):1467-70

Green A, Purdie D, Bain C, Siskind V, Webb PM. Cigarette smoking and risk of epithelial ovarian cancer. Cancer Causes and Control 2001; Vol 12 (8): 713-719

Modugno F, Ness RB, Cottreaus CM. Cigarette Smoking and the Risk of Mucinous and Nonmucinous Epithelial Ovarian Cancer. Epidemiology 2002; 13 (4): 467-471

Fleischauer AT, Olson SH, Mignone L, Simonsen N, Caputo TA, Harlap S. Dietary Antioxidants, Supplements, and Risk of Epithelial Ovarian Cancer. Nutr Cancer 2002; 40 (2). 92-98

Goodman MT, Wu AH, Tung KH, McDuffie K, Kolonel LN, Nomura AMY, Terada K, Wilkens LR, Murphy S, Hankin JH. Association of Diary Products, Lactose, and Calcium with the Risk of Ovarian Cancer. am J Epidemiol 2002; 156: 148-157

Wolter C. Luppa P, Breul J, Fink U, Hanauske A, Präuer HW, Sendler A, Wilhelm O, Neumeier D. Humorale Tumormarker, Deutsches Ärzteblatt 1996; 93 (50): 3346-3351

Pfleiderer A, Stosiek U, Trams G. Zytostatikatherapie, gynäkol. prax. 1979; (3): 295-296

Dibble SL;, Roberts SA, Robertson PA, Paul SM. Risk factors for ovarian cancer: lesbian and heterosexual women. Oncol Nurs Forum 2002; 29 (1): E1-7

Rubin SC. Chemoprevention of Hereditary Ovarian Cancer. N Engl J Med. 1998; Vol 339 (7): 469-471

Narod SA, Risch H, Moslehi R, dorum A, Neuhausen S, Olsson H, Provencher D, Radice P et al. Oral Contraceptives and the Risk of Hereditary Ovarian Cancer. N Engl J Med 1998; Vol 339 (7): 424-428

Schildkraut JM, Calingaert B, Marchbanks PA, Moorman PG, Rodrigues GC et al. Impact of Progestin and Estrogen Potency in Oral Contraceptives on ovarian Cancer risk. J Natl Cancer 2002; 94 (1): 32-38

Kieback G. Screening von Mamma- und Ovarialkarzinomen, Frauenarzt, 1997, 4: 700-702

Mall P. Mastalgie - Mastodynie. Frauenarzt 1996, 37 (5): 774-774

Schultz KD, Albert US. Brustgesundheit. Ein wesentlicher Bestandteil frauenärztlicher Verantwortung. Gynäkologe, 2002; 35: 881-886

Von Fournier D, Kubli F, Bauer M, Mehringer R. Behandlung der Mastopathie. gynäkol prax 1979, 3: 511-520

Wendtland RS. Mammographie, frauenheilkunde plus 1998; 3: 125-7

Bock K, Duda VF, Albert US, Schulz KD. Hormonale Einflüsse auf die mammographische Gewebsdichte. Gynäkologe 2002; 35:1087-1093

Duda VF, Albert US. Mammasonographie im Aufwind, gyn 1997; 82: 173-184

Madjar H. Dopplersonographie in der Differentialdiagnose von Mammatumoren, Georg Thieme Verlag Stuttgart New York 1995.

Tumorzentrum München. Empfehlungen zur Diagnostik, Therapie und Nachsorge Mammakarzinome. 6. Auflage 1996.

Maas H. Selektionskriterien der brusterhaltenden Therapie des Mammakarzinoms, gyn 1997; 2: 198-203

Beilage für Gynäkologen. Adjuvante Systemtherapie des primären Mammakarzinoms, Springer Verlag 1995.

Kuhl H, Runnebaum B, Schneider HPG. Langfristige Hormonsubstitution und Mammakarzinomrisiko: Aktuelle Bestandsaufnahme, Frauenarzt, 1995; 10: 1117-1121

Dixon JM. Hormone replacement therapy and the breast. BMJ 2001; 323: 1381-1382

Marchbanks PA, McDonald JA, Wilson HG, Folger SG, Mandel MG, Daling JR, Bernstein L et al. Oral Contraceptives and the Risk of Breast Cancer. N Engl J Med 2002; vol 346 (26): 2025-2032

Hellriegel KP. Nachsorge bei Mammakarzinompatientiennen, gynäkol. prax. 1996; 20: 327-331

Beilage für Onkologen: Fortschritte in der Therapie des metastasierten Mammakarzinoms. Springer Verlag 1996.

Possinger K. Mammakarzinom, Therapie bei Metastasierung. TW Gynäkologie 1996; 9: 319-328

Cserni G. Sentinel lymph-node biopsy-based prediction of further breast cancer metastases in the axilla. EJSO 2001; Vol 27 (6): 532-538

Dixon JM. Hormone replacement therapy and the breast. B Med J 2001; Vol 323: 1381-1382

Chen CL, Weiss NS, Newcomb P, Barlow W, White E. Hormone Replacement Therapy in Relation to Breast Cancer. JAMA 2002; Vol 287 (6): 734-741

ATAC Trialists group. Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the 'Arimidex and tamoxifen alone or in combination' (ATAC) trial. Br J Cancer 2001; Vol 85 (3): 317-24

Dixon JM, Love CD, Belloamy CO, Cameron DA, Leonard RC, Smith H, Miller WR. Letrozole as primary medical therapy for locally advanced and large operable breast cancer. Breast CAncer Res Treat 2001; 66 (3): 191-199

Mouridsen H, Gerschanovich M, Sun Y, Peres-Carrion R, Boni C, Monnier A et al. Superior efficacy of letrosole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a physe III study of the International Letrozole Breast Cancer Group. J Clin Oncol 2001, 19 (10): 2596-606

Ellison RC, Zhang Y, McLennan CE, Rothman KJ. Exploring the Relation of Alcohol Consumption to Risk of Breast Cancer. Am J Epidemiol 2001; Vol 154 (8): 740-747

Ching S, Ingram D, Hahnel R, Beilby J, Rossi E. Serum levels of Micronutrients Antioxidants and Total Antioxidant Status Predict Risk of Breast Cancer in a Case Control Study. J Nutr 2002; Vol 132: 303-306

Toniolo P, Van Kappel AL, Akhmedkhanov A, Ferrari P, Kato I, Shore RE, Riboli E. Serum Carotenoids and Breast Cancer. Am J Epidemiol 2001; Vol 153 (12): 1142-1147

Innes K, Byers T, Schymura M. Birth Characteristics and Subsequent Risk for Breast Cancer in Very Young Women. Am J Epidem 2000; Vol 152 (12): 1121-1128

Gogas J, Kouskos E, Tseleni-Balafouta S, Markopoulos C, Revenas K, Gogas G, Kostakis A. Autoimmune thyreoid disease in women with breast carcinoma. EJSO 2001; Vol 7: 626-630

Friedenreich CM, Courneya KS, Bryant HE. Influence of Physical Activity in Different Age and Life Periods on the Risk of Breast Cancer. Epidemiology 2001; 12: 604-512

Danish Cancer Society. Increased breast cancer risk among women who work predominantly at night. Epidemiol 2001; 12 (1). 74-7

Tryggvadottir L, Tulinius H, Eyfjord JE, Siurvinsson T. Breastfeeding and Reduced Risk of Breast Cancer in an Icelandic Cohort Study. am J Epidemiol 2001, 154 (1). 37-42

Cancer Reserach UK Epidemiology Unit, Univsersity of Oxford. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer 2002; 94 (8): 606-616

Dos Santos Silva I, Mangtani P, McCormack V, Bhakta D, Sevak L, McMichael AJ. Lifelong vegetarianism and risk of breast cancer: A population-based case-control study among South Asian migrant women living in England. Int J Cancer 2002; 99 (2): 238-244




U izradi stranice Utjecaj prehrane na nastanak raka korištene su sljedeće reference:


Wirthensohn G, Petri E, Kaffenberger W, Altwein JE. Diät und Mammakarzinom. Frauenarzt 1998; 10: 1558-1568

Fabian CJ. Breast cancer chemoprevention: beyond tamoxifen. Breast Cancer Res 2001; 3(2):99-103

Kelloff GJ; Lieberman R; Steele VE; Boone CW; Lubet RA; Kopelovich L; Malone WA; Crowell JA; Higley HR; Sigman CC. Agents, biomarkers, and cohorts for chemopreventive agent developement in prostate cancer. Urology 2001 Apr; 57 (4 Suppl 1): 46-51

Hakkak R; Korourian S; Ronis MJ; Johznston JM; Badger TM. Soy protein isolate consumption protects against azoxymethane-induced colon tumors in male rats. Cancer Lett 2001 May 10; 166(1): 27-32

Watzl B, Leitzmann C. Bioaktive Substanzen in Lebensmitteln. Hippokrates Verlag Stuttgart 1995: 19-25.

van't Veer P, Dekker JM, Lamers JWJ. Consumption of fermented milk products and breast cancer: a case-control study in the Netherlands. Cancer Res 1989; 49: 4020-4023

Toniolo P, Van Kappel AL, Akhmedkhanov A, Ferrari P, Kato I, Shore RE; Riboli E. Serum carotenoids and breast cancer. Am J Epidemiol 2001 Jun;153(12): 1142-7

Messina M. Phytate's potential role in reducing colon-cancer risk. Amer J Clin Nutr 1991; 54: 762-763

Cram EJ, Liu BD, Bjeldanes LF, Firestone GL. Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Spl transcription factos interaction with a composite element in the DK6 gene promoter. J Biol Chem 2001 Jun; 276(5): 22332-40

Yang CS, Landau JM, Huang MT, Newmark HL. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 2001; 21: 381-406

Dittmann K, Knaus-Dittmann D, Mayer C, Rodemann HP. Bowman-Birk proteinase inhibitor-mediated radioprotection against UV irradiation is TP53-dependent and associated with stimulation of nucleotide excision repair. Radiat Environ Biophys 2001 Jun;40(2): 163-7

Kaji I, Tatsuta M, Iishi H, Baba M, Inoue A, Kasugai H. Inhibition by d-limonene of experimental hepatocarcinogenesis in Sprague-Dawley rats does not involve p21(ras) plasma membrane association. Int J Cancer 2001 Aug 1;93(3): 441-4

Gould MN, Moore CJ, Zhang R. Limonene chemoprevention of mammary carcinoma induction following direct in situ transfer of v-Ha-ras. Cancer Res 1994; 54: 3540-3543

Dorant E. Consumption of onions and a reduced risk of stomach carcinoma. Gastroenterol. 1996;110: 1220

Boersma BJ, Barnes S, Kirk M, Wang C, Smith M, Kim H, Xu J, Patel R, Darley-Usmar VM. Soy isoflavonoids and cancer - metabolism at the target site. Mutat Res 2001 Sep; 480-481 (1-2): 121-7

Krazeisen A, Breitling R, Moller G, Adamski J. Phytoestrogens inhibit human 17beta-hydroxysteroid dehydrogenase type 5. Mol Cell Endocrinol 2001 Jan; 171(1-2): 151-62

Dai Q, Shu YO, Jin F, Potter JD, Kushi LH, Teas J, Gao YT, Zheng W. Population-based case-control study od soyfood intake and breast cancer risk in Shangai. Br J Cancer 2001 Aug;85(3): 372-8

Sirtori CR. Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis. Drug Saf 2001; 24(9): 665-82




U izradi stranice Rak dojke, ekološki činioci i prehrana korištene su sljedeće reference:


Adzersen KH, Eustachi A, Gerhard I. Arbeitsgemeinschaft Naturheilkunde und Umweltmedizin (NATUM). Stellungnahme zu Umwelt, Ernährung und Brustkrebs. Frauenarzt, 1999; 10: 1233-1239

Sharpe C; Boivin JF. The Etiology of Female Breast Cancer. Medical Principles and Practice 2000; 9 (1): 1-24

Hulka BS; Moorman PG. Breast cancer: hormones and other risk factores. Maturitas 2001; 38 (19): 103-113

Martin FL. Genotoxins and the initation of sporadic breast cancer. Mutagenesis 2001; 16 (2): 155-61

Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med 2001; 344 (4): 276-285

Lippman ME; Krueger KA; Eckert S; Sashegyi A; Walls EL; Jamal S; Cauley JA; Cummings SR. Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participants. J Clin Oncol 2001; 19 (12): 3111-3116

Verkasalo PK; Thomas HV; Appleby PN; Davey GK; Key TJ. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control 2001; 12 (1): 47-59

Levi F; Paache C; Lucchini F; La Vecchia C. Dietary intake of selected micronutrients and breast-cancer risk. Int J Cancer 2001; 91 (29):260-263

Moorman PG; Ricciuti MF; Millikan RC; Newman B. Vitamin supplement use and breast cancer in a North Carolina population. Public Health Nutr 2001; 4 (3): 821-827

Snedeker SM. Pesticides and breast cancer risk: a rewiev of DDT, DDE and dieldrin. Environ Health Perspect 2001; 109 Suppl 1: 35-47

Manjer J; Malina J; Berglund G; Bondeson L; Garne JP; Janzon L. Smoking associated with hormone receptor negative breast cancer. Int J Cancer 2001; 91 (4): 580-54

Singletary KV; Frey RS; Yan W. Effect of ethanol on proliferation and estrogen receptor-alpha expression in human breast cancer cells. Cancer Lett 2001; 165 (2): 131-137

Sellers TA; Kushi LH; Cerhan JR; Vierkant RA; Gapstur SM; Vachon CM; Olson JE; Thernau TM; Folsom AR. Dietary Folate Intake, Alcohol, and Risk of Breast Cancer in a Prospective Study of Postmenopausal Women. Epidemiology 2001 July; 12(4): 420-428

Bogen KT; Keating GA. U.S. dietary exposures to heterocyclic amines. J Expo Anal Environ Epidemiol 2001; 11 (3): 155-168

Zheng W; Wie D; Cerhan JR; Sellers TA; Wen W; Folsom AR. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001; 10 (2): 89-94.

La Guardia M; Giammanco M. Breast cancer and obesity. Panminerva med 2001; 43 (2): 123-133

Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 2001; 10 (1): 15-32

Smith-Warner SA; Spiegleman D; Adami HO; Beeson WL, van den Brandt PA; Folsom AR; Fraser GE; Freudenheim JL; Goldbohm RA; Graham S; Kushi LH; Miller AB; Rohan TE; Speizer FE; Toniolo P; Willett WC; Wolk A; Zeleniuch-Jacquotte A; Hunter DJ. Types of diatary fat and breast cancer: a pooled analysis of cohort studies. Int J Cancer 2001; 92 (5): 767-774

Alarcon de la Lastra C; Barranco MD; Motilva V; Herreiras JM. Mediterranean diet and health: biological importance of olive oil. Curr Pharm Des 2001; 7 (10): 933-950

Yoo K; Tajima K; Park S; Kang D; Kim S; Hirose K; Takeuchi T; Miura S. Postmenopausal obesity as a breast cancer risk factor according to estrogen and progesterone receptor status (Japan). Cancer Lett 2001; 167 (1): 57-63

Howarth NC; Saltzman E; Roberts SB. Dietary fiber and weight regulation. Nutr Rev 2001; 59 (5): 129-139

Toniolo P; Van Kappel AL; Akhmedkhanov A; Ferrari P; Kato I; Shore RE; Riboli E. Serum carotenoids and breast cancer. Am J Epidemiol 2001; 153 (12): 1142-1147

Shrubsole MJ; Jin F; Dai Q; Shu XO; Potter JD; Heber JR; Gao YT; Zheng W. Dietary folate intake and breast cancer risk: results from the Shagai breast study. Cancer Res 2001; 61 (19): 7136-7141

Pietinen P; Stumpf K, Mannisto S, Kataja V; Uusitupa M; Alercreutz H. Serum enterolactone and risk of breast cancer: a case-control study in eastern Finnland. Cancer Epidemiol Biomarkers Prev 2001; 10 (4): 339-344

Hansen J. Increased breast cancer among women who work predominantly at night. Epidemiology 2001; 12 (1): 74-77

Lucena RA; Allam MF; Costabeber IH; Villarejo ML; Navajas RF. Breast cancer risk factors: PCB congeners. Eur J Cancer Prev 2001; 10 (1): 117-119

Woolcott CG; Aronson KJ; Hanna WM; Sen Gupta SK; McCready DR; Sterns EE; Miller AB. Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada). Cancer Causes Control 2001; 12 (5): 395-404

Laden F; Collman G; Iwamoto K; Algerg AJ; Berkowitz GS; Freudenheim JL; Hrankinson SE; Helzlsouer KJ; Holford TR; Huang HY; Moysich KB; Tessari JD; Wolff MS; Zheng T; Hunter DJ. 1,1 Dichloro-2,2-bis(p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five U.S.studies. J Natl Cancer Inst 2001; 93 (10): 768-776

Ray G; Husain SA. Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem 2001; 34 (1): 71-76

Cram EJ; Liu BD; Bjeldanes LF; Firestone GL. Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Sp1 transcription factor interactions with a composite element in the CDK6 gene promoter. J Biol Chem 2001; 276 (25): 22332-22340

Tymchuk CN; Tessler SB; Barnard RJ. Changes in sex homone-binding globulin, insulin, and serum lipids in postmenopausal women on a low-fat, high-fiber diet combined with exercise. Nutr Cancer 2000; 38 (2): 158-162
Literatura